As Boston Scientific Corp (BSX) Shares Were Volatile, Sei Investments Company Raised Its Holding by $20.58 Million

May 19, 2017 - By Darrin Black

Sei Investments Company increased its stake in Boston Scientific Corp (BSX) by 23.97% based on its latest 2016Q4 regulatory filing with the SEC. Sei Investments Company bought 980,101 shares as the company’s stock 0.00% . The institutional investor held 5.07M shares of the medical and dental instruments company at the end of 2016Q4, valued at $109.63M, up from 4.09 million at the end of the previous reported quarter. Sei Investments Company who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $36.42B market cap company. The stock rose 0.96% or $0.25 reaching $26.39 per share. About 5.77M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Sei Investments Company, which manages about $20.65B US Long portfolio, decreased its stake in Prologis Inc (NYSE:PLD) by 109,151 shares to 1.18 million shares, valued at $62.39 million in 2016Q4, according to the filing. It also reduced its holding in Netease Inc (NASDAQ:NTES) by 29,467 shares in the quarter, leaving it with 31,127 shares, and cut its stake in Medtronic Plc (NYSE:MDT).

Investors sentiment decreased to 0.84 in 2016 Q4. Its down 0.28, from 1.12 in 2016Q3. It dropped, as 67 investors sold BSX shares while 195 reduced holdings. 60 funds opened positions while 161 raised stakes. 1.23 billion shares or 1.80% more from 1.21 billion shares in 2016Q3 were reported. Cornerstone Advisors has invested 0.04% in Boston Scientific Corporation (NYSE:BSX). Earnest Prns Ltd reported 651 shares or 0% of all its holdings. 5.76M were accumulated by Prudential Financial. 10.57M were reported by Capital Research Glob Invsts. Virtu Lc holds 0.03% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 13,039 shares. Renaissance Technologies Ltd Com reported 0.09% in Boston Scientific Corporation (NYSE:BSX). The Pennsylvania-based Janney Montgomery Scott Limited Liability has invested 0.02% in Boston Scientific Corporation (NYSE:BSX). Lba Wealth Mngmt Ltd Liability Company has 0.01% invested in Boston Scientific Corporation (NYSE:BSX). Weiss Multi holds 0.07% in Boston Scientific Corporation (NYSE:BSX) or 70,452 shares. Riverhead Capital Limited Liability Corp accumulated 209,833 shares. Price Michael F holds 700,000 shares. Marshall Wace Ltd Liability Partnership stated it has 3.67M shares or 0.52% of all its holdings. Deutsche Savings Bank Ag holds 0.04% or 2.45M shares in its portfolio. Blackrock Advisors Limited Co holds 0.23% of its portfolio in Boston Scientific Corporation (NYSE:BSX) for 10.69M shares. Cibc World Mkts stated it has 0.02% in Boston Scientific Corporation (NYSE:BSX).

Since December 1, 2016, it had 0 insider purchases, and 16 sales for $9.25 million activity. 26,726 shares were sold by Pratt Timothy A., worth $547,367 on Thursday, December 1. Mirviss Jeffrey B. also sold $616,663 worth of Boston Scientific Corporation (NYSE:BSX) on Tuesday, February 28. Thepaut Eric Francis Yves sold $592,858 worth of stock or 23,775 shares. Another trade for 10,232 shares valued at $227,546 was made by Pierce David A on Monday, January 9. Shares for $739,134 were sold by Dawkins Keith D. Another trade for 2,950 shares valued at $72,747 was sold by Sorenson John Bradley. Phalen Michael P. sold 15,500 shares worth $408,778.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: which released: “Boston Scientific Closes Symetis Acquisition” on May 16, 2017, also with their article: “The Boston Scientific LOTUSâ„¢ Valve System Demonstrated Superior Efficacy to …” published on May 16, 2017, published: “Boston Scientific’s Symetis Buyout Boosts Structural Heart” on May 18, 2017. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: and their article: “Boston Scientific Hits a 52-Week High on Solid Prospects” published on May 17, 2017 as well as‘s news article titled: “Boston Scientific Announces Scheduled Presentations at Heart Rhythm Society 2017” with publication date: May 03, 2017.

Boston Scientific Corporation (NYSE:BSX) Ratings Coverage

Among 25 analysts covering Boston Scientific Corporation (NYSE:BSX), 19 have Buy rating, 0 Sell and 6 Hold. Therefore 76% are positive. Boston Scientific Corporation had 35 analyst reports since July 27, 2015 according to SRatingsIntel. On Monday, August 10 the stock rating was reinitiated by Credit Suisse with “Outperform”. The firm earned “Buy” rating on Thursday, February 25 by Suntrust Robinson. The company was initiated on Thursday, November 12 by Citigroup. The stock has “Outperform” rating by RBC Capital Markets on Thursday, April 28. The firm earned “Buy” rating on Friday, February 3 by Needham. BTIG Research downgraded the shares of BSX in report on Monday, May 23 to “Neutral” rating. The stock has “Buy” rating by Argus Research on Thursday, September 1. The firm has “Corporate” rating by FinnCap given on Thursday, October 29. The firm has “Buy” rating by Guggenheim given on Thursday, June 9. The rating was initiated by Nomura with “Buy” on Thursday, March 17.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.